Explore
Validate
LearnTissue expression
Cell line expression
Protein structure
GMPS
Guanine monophosphate synthaseGATD7
In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP. [provided by RefSeq, Jul 2008]
Top validated antibodies |
|||||
| Proteintech Group |  16376-1-AP |
4 references | Polyclonal |
WB
EL
IP
IHC
|
|
| Novus Biologicals | H00008833-M01 |
1 references | Monoclonal |
WB
EL
IHC
FC
|
|
| antibodies-online | ABIN2839555 |
2 references | Polyclonal |
WB
IHC
FC
|
|
| Invitrogen Antibodies | 16376-1-AP |
Polyclonal |
WB
IP
IHC
OA
|
||
| Aviva Systems Biology | OAAB01744 |
Polyclonal |
WB
EL
IHC
FC
|
||
All Antibodies
Filters
Enhanced validation Supportive data in Antibodypedia Data presented on provider website
Data in Antibodypedia (inconclusive) Recommended by provider